Application 075615
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CROMOLYN SODIUM | CROMOLYN SODIUM | SOLUTION/DROPS;OPHTHALMIC | 4% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075615-001 | CROMOLYN SODIUM | CROMOLYN SODIUM | 4% | SOLUTION/DROPS / OPHTHALMIC | 2001-01-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A075615-001 | CROMOLYN SODIUM | 4% | SOLUTION/DROPS / OPHTHALMIC | 2001-01-26 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075615-001 | CROMOLYN SODIUM | 4% | SOLUTION/DROPS / OPHTHALMIC | 2001-01-26 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075615-001 | CROMOLYN SODIUM | 4% | SOLUTION/DROPS / OPHTHALMIC | 2001-01-26 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NasalCrom | CROMOLYN SODIUM | Prestige Brands Holdings, Inc. | b34d36ca-4df4-458c-af0f-c0d0c9a025d9 | 2026-06-03 | Warnings | CROMOLYN SODIUM |
| Cromolyn Sodium | CROMOLYN SODIUM | Preferred Pharmaceuticals Inc. | 18892411-465f-4d8d-9550-7dafa6c6a0a3 | 2026-04-01 | Adverse reactions | Cromolyn Sodium CROMOLYN SODIUM |
| CROMOLYN SODIUM | CROMOLYN SODIUM | Omnivium Pharmaceuticals LLC | a742664b-265e-49f9-9744-d04e1fb620ae | 2026-01-13 | Warnings, Adverse reactions | CROMOLYN SODIUM CROMOLYN SODIUM |
| Cromolyn Sodium | CROMOLYN SODIUM | Sandoz Inc | b32851c3-cd97-4be4-a09c-1deab1d6966b | 2025-02-20 | Adverse reactions | Cromolyn Sodium CROMOLYN SODIUM |
| Cromolyn Sodium | CROMOLYN SODIUM | A-S Medication Solutions | 0d30fb0a-e343-426d-8203-5816bd4cec2f | 2024-11-07 | Adverse reactions | Cromolyn Sodium CROMOLYN SODIUM |
| CROMOLYN SODIUM | CROMOLYN SODIUM | Micro Labs Limited | 93f80edb-3b38-423e-8cd6-5b5cb4393ec2 | 2024-09-26 | Warnings, Adverse reactions | CROMOLYN SODIUM CROMOLYN SODIUM |
| Gastrocrom | CROMOLYN SODIUM | Viatris Specialty LLC | 00623958-a8fe-47d1-a0d2-0aa4e2f7966e | 2024-06-26 | Warnings, Adverse reactions | CROMOLYN SODIUM |
| Cromolyn Sodium | CROMOLYN SODIUM | Teva Pharmaceuticals USA, Inc. | 8fe37a7a-edd6-4733-bb7e-e01c1906aeba | 2023-12-14 | Warnings, Adverse reactions | Cromolyn Sodium CROMOLYN SODIUM |
| CROMOLYN SODIUM | CROMOLYN SODIUM | Rising Pharma Holdings, Inc. | 61c9cb85-129e-4490-b5f7-357307fcecbf | 2021-08-01 | Warnings, Adverse reactions | CROMOLYN SODIUM CROMOLYN SODIUM |
| Cromolyn Sodium | CROMOLYN SODIUM | Bausch & Lomb Incorporated | 379f4b59-6866-4b5c-9b1b-d8a35b741461 | 2021-06-01 | Warnings | Cromolyn Sodium CROMOLYN SODIUM |
| Cromolyn Sodium | CROMOLYN SODIUM | Proficient Rx LP | 34ef00e8-0c01-4225-9a40-822ab245752a | 2019-10-01 | Adverse reactions | Cromolyn Sodium CROMOLYN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 30957 | ORIG | 2001-01-26 |